Drug recalls
Every medicine recall reported to the FDA since 2012, newest first. Last checked for new ones 15 hours ago.
22 recalls
- Class II Ferrous Sulfate 7.5 mg Iron/0.5 mL Oral Syringe, Delivers: 0.5 mL, Iron Supplement Drops, Mfg by: Akron Pharma, Pkg by: Safecor, Columbus, OH 43204. Defective Delivery System: Leakage observed after oral solution was repackaged into unit-dose syringes. Safecor Health, LLC · Mar 12, 2025 · Ongoing
- Class II Ferrous Sulfate Iron Supplement Drops, packaged in 50 mL bottles, Distributed by: Akorn Operating Company LLC, Gurnee, IL 60031. ALL NDCs CGMP Deviations: Firm went out of business and could no longer continue stability studies. Akorn, Inc. · Jun 7, 2023 · Ongoing
- Class II Ferrous Sulfate 75 mg (equivalent to 15 mg Iron) Per 1.0 mL Alcohol 0.2% v/v Drops Iron Supplement Drops For Infants and Toddlers 50 mL (1 2/3 fl oz) NDC 54838-… CGMP Deviations: Intermittent exposure to temperature excursion during storage. Cardinal Health Inc. · Jun 2, 2021 · Terminated
- Class II Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) chewable,1 mg/0.02 mg/75 mg, Rx Only, Provides 24 days of activ… Failed Impurities/Degradation Specifications: Out of specification result observed in related substance test. Lupin Pharmaceuticals Inc. · Aug 19, 2020 · Terminated
- Class II Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals In… Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack. Lupin Pharmaceuticals Inc. · Jan 15, 2020 · Terminated
- Class II Kaitlib Fe norethindrone and ethinyl estradiol chewable tablets (0.8 mg/0.025 mg) and Ferrous Fumarate, Chewable Tablets, Rx Only, Distributed by: Lupin Pharmac… Failed Impurities/Degradation Specifications: Kaitlib Fe Tablets has an out of specification result observed in long term stability study. Lupin Pharmaceuticals Inc. · Aug 7, 2019 · Terminated
- Class II Preferred Plus Pharmacy Iron Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. cGMP Deviations: Products may have microbial contamination. Geritrex, LLC · Jul 31, 2019 · Terminated
- Class II Gericare Iron Supplement Elixir Ferrous Sulfate, 220 mg, 16 fl oz. (473 mL), Distributed by: Geri-care Pharmaceuticals Corp. cGMP Deviations: Products may have microbial contamination. Geritrex, LLC · Jul 31, 2019 · Terminated
- Class II Gericare Iron Supplement Elixir Ferrous Sulfate 220 mg, packaged in 16 fl oz. (473 mL) bottles, Dist by: Gericare Pharmaceuticals Corp. CGMP Deviations: Products are being recalled due to an out of specification total aerobic microbial count in a water sample. RIJ Pharmaceutical LLC · Jun 20, 2018 · Terminated
- Class III Ferrous Sulfate 325 MG tablet; NDC 33261-0715-00 Presence of Foreign Tablets/Capsules Aidarex Pharmaceuticals LLC · May 23, 2018 · Terminated
- Class I Mibelas 24 Fe (Norethindrone acetate and Ethinyl estradiol 1 mg/0.02 mg chewable and ferrous Fumarate 75 mg) Tablets, wallet of 28 tablets (NDC 68180-911-11), C… Contraceptive Tablets Out of Sequence- First 4 pills of the packet are brown, instead of the last four pills and the expiry/lot was not printed on the package. Lupin Limited (Unit 1) · Aug 23, 2017 · Terminated
- Class III Tarina Fe 1/20 (Norethindrone Acetate and Ethinyl Estradiol Tablets, USP and Ferrous Fumarate Tablets), 1 blister pack containing 28 tablets (NDC 50102-128-01),… Chemical Contamination: out of specification results for impurities were found to be the result of contamination of product from vapors associated with paint th… Mylan Pharmaceuticals Inc. · May 31, 2017 · Terminated
- Class III Gildess 24 FE 1.5/30 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, (a) 3 blisters… Subpotent Drug; Ethinyl Estradiol Par Pharmaceutical, Inc. · Nov 9, 2016 · Terminated
- Class III Gildess FE 1.5/30 (norethindrone acetate, 1.5 mg and ethinyl estradiol tablets, 0.03 mg, USP and ferrous fumarate tablets, USP 75 mg), 6 blisters (28 count), ND… Subpotent Drug; Ethinyl Estradiol Par Pharmaceutical, Inc. · Nov 9, 2016 · Terminated
- Class III Gildess FE 1/20 (norethindrone acetate, 1 mg and ethinyl estradiol tablets, 0.02 mg, USP and ferrous fumarate tablets, USP 75 mg), 28 count, 6 blisters (NDC 060… Subpotent Drug; Ethinyl Estradiol Par Pharmaceutical, Inc. · Nov 9, 2016 · Terminated
- Class II TOLTERODINE TARTRATE ER, Capsule, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00009519001. Labeling: Label Mixup: TOLTERODINE TARTRATE ER, Capsule, 2 mg may be potentially mislabeled as one of the following drugs: RANOLAZINE ER , Tablet, 500 mg, NDC 6… Aidapak Services, LLC · Jan 29, 2014 · Terminated
- Class II CINACALCET HCL Tablet, 30 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 55513007330 Labeling:Label Mixup; CINACALCET HCL, Tablet, 30 mg may be potentially mislabeled as ACETAMINOPHEN, Chew Tablet, 80 mg, NDC 00536323307, Pedigree: W003113, EXP:… Aidapak Services, LLC · Jan 22, 2014 · Terminated
- Class II FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904759160 Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elemental Iron) may be potentially mislabeled as RAMIPRIL, Capsule, 2.5 mg, NDC 68180058901, Pedig… Aidapak Services, LLC · Jan 22, 2014 · Terminated
- Class II FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe), Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904759160 Labeling: Label Mixup; FERROUS SULFATE, Tablet, 325 mg (65 mg Elem Fe) may be potentially mislabeled as COENZYME Q-10, Capsule, 100 mg, NDC 37205055065, Pedigre… Aidapak Services, LLC · Jan 22, 2014 · Terminated
- Class III Junel(TM) Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets, USP and ferrous fumarate tablets), 28 day regimen, Rx only, Barr laboratories, Pomona,… Failed Impurity/Degradation Specification; an impurity identified as N-Butyl-Benzene Sulfonamide (NBBS) was detected during impurity testing Teva Pharmaceuticals USA, Inc. · Jul 17, 2013 · Terminated